The potential effect and mechanism of high-mobility group box 1 protein on regulatory T cell-mediated immunosuppression

Journal of Interferon and Cytokine Research

Volumn 31, Issue 2, 2011, Pages 249-257

  Zhang, Ying ^a   Yao, Yong Ming ^a   Huang, Li Feng ^a   Dong, Ning ^a   Yu, Yan ^a   Sheng, Zhi Yong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL SUSPENSION; CELLULAR IMMUNITY; CYTOKINE RELEASE; DOWN REGULATION; GENE EXPRESSION; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGENS, CD; CELL PROLIFERATION; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HMGB1 PROTEIN; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; MALE; MICE; MICE, INBRED BALB C; SPLEEN; T-LYMPHOCYTES, REGULATORY; TH1-TH2 BALANCE;

MUS;

EID: 79951848606     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2010.0019     Document Type: Article

References (51)

1. Allez M, Mayer L. 2004. Regulatory T cells peace keepe (Pubitemid 39276480)
2. Bacchetta R, Gregori S, Roncarolo MG. 2005. CD4+ regulatory T cells: mechanisms of induction and effector function. Autoimmun Rev 4:491-496. (Pubitemid 41415758)
3. Belkaid Y, Rouse BT. 2005. Natural regulatory T cells in infectious disease. Nat Immunol 6:353-360. (Pubitemid 41716772)
4. Börgermann J, Flohé S, Scheubel RJ, Kuss O, Simm A, Schade FU. 2007. Regulation of cytokine synthesis in cardiac surgery: role of extracorporeal circuit and humoral mediators in vivo and in vitro. Inflamm Res 56:126-132. (Pubitemid 46570796)
5. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J. 2003. Regulatory T cells selectively express Toll- Like receptors and activated by lipopolysaccharide. J Exp Med 197:403-411. (Pubitemid 36278597)
6. Chatila TA. 2005. Role of regulatory T cells in human diseases. J Allergy Clin Immunol 116:949-959.
7. Chen G, Ward MF, Sama AE, Wang H. 2004. Extracellular HMGB1 as a proinflammatory cytokine. J Interferon Cytokine Res 24:329-333. (Pubitemid 38781691)
8. Choileain NN, Redmond HP. 2006. Regulatory T-cells and autoimmunity. J Surg Res 130:124-135. (Pubitemid 43028574)
9. Coffer PJ, Burgering BM. 2004. Forkhead box transcription factors and their role in the immune system. Nat Rev Immunol 4:889-899. (Pubitemid 39490764)
10. Cook DN, Hollingsworth JW, Schwartz DA. 2003. Toll-like receptors and the genetics of innate immunity. Curr Opin Allergy Clin Immunol 3:523-529. (Pubitemid 39149568)
11. Das G, Sheridan S, Janeway CA. 2001. The source of early IFNgamma that plays a role in Th1 priming. J Immunol 167:2004-2010. (Pubitemid 32747507)
12. El Gazzar M. 2007. HMGB1 modulates inflammatory responses in LPS-activated macrophages. Inflamm Res 56:162-167. (Pubitemid 47164931)
13. Ellerman JE, Brown CK, de Vera M. 2007. Masquerader: high mobility group box-1 and cancer. Clin Cancer Res 13:2836-2846.
14. Fantini MC, Becker C, Monteleone G, Pallone F, Galle PR, Neurath MF. 2004. TGF-beta induces a regulatory phenotype in CD4+CD25+ T cells through Foxp3 induction and downregulation of Smad7. J Immunol 172:5149-5153. (Pubitemid 38542009)
15. Fehervari Z, Sakaguchi S. 2004. Development and function of CD25+CD4+ regulatory T cells. Curr Opin Immunol 16:203-208. (Pubitemid 38332029)
16. Fontenot JD, Gavin MA, Rudensky AY. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330-336. (Pubitemid 36432314)
17. Goleva E, Cardona ID, Ou LS, Leung DY. 2005. Factors that regulate naturally occurring T regulatory cell-mediated suppression. J Allergy Clin Immunol 116:1094-1110.
18. Harald VB. 2005. Mechanisms of suppression by suppressor T cells. Nat Immunol 6:338-344.
19. Jonulei H, Schmitt E. 2003. The regulatory T cell family: distinct subsets and their interrelations. J Immunol 171:6323-6327. (Pubitemid 37532056)
20. Kingsley CI, Karim M, Bushell AR, Wood KJ. 2002. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4 and IL-10- dependent immuno-regulation of alloresponses. J Immunol 168:1080-1086. (Pubitemid 34094471)
21. Kokkola R, Andersson A, Mullins G. 2005. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 61:1-9. (Pubitemid 40188342)
22. Kubo Y, Nakano K. 1999. Regulation of histamine synthesis inmouse CD4+ and CD8+ T lymphocytes. Inflamm Res 48:149-153. (Pubitemid 29137665)
23. Lewkowicz P, Lewkowicz N, Sasiak A, Tchórzewski H. 2006. Lipopolysaccharide-activated CD4+CD25+ T regulatory cells inhibit neutrophil function and promote their apoptosis and death. J Immunol 177:7155-7163. (Pubitemid 44715084)
24. Lin W, Haribhai D, Relland LM. 2007. Regulatory T cell development in the absence of functional Foxp3. Nat Immunol 8:359-368. (Pubitemid 46745411)
25. Liu H, Komai-Koma M, Xu D, Liew FY. 2006. Toll-like receptor 2 signaling modulates the functions of CD4+CD25+ regulatory T cells. Proc Natl Acad Sci U S A 103:7048-7053.
26. Lu Y, Xu W, Zhou Y, Lv P, Gao XM. 2006. Regulatory activity of activated murine peripheral CD4+ CD25- T cells: a possible mechanism of feedback regulation on adaptive immunity. Scand J Immunol 64:500-506. (Pubitemid 44536334)
27. Lundy SK, Berlin AA, Martens TF, Lukacs NW. 2005. Deficiency of regulatory B cells increases allergic airway inflammation. Inflamm Res 54:514-521. (Pubitemid 43042239)
28. MacConmara MP, Maung AA, Fujimi S. 2006. Increased CD4+CD25+ T regulatory cell activity in trauma patients depresses protective Th1 immunity. Ann Surg 244:514-523.
29. Mills KH. 2004. Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 4:841-855. (Pubitemid 39490760)
30. Miyara M, Sakaguchi S. 2007. Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 13:108-116. (Pubitemid 46341958)
31. Park JS, Gamboni-Robertson F, He Q. 2006. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 290:C917-C924.
32. Park JS, Svetkauskaite D, He Q. 2004. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279:7370-7377. (Pubitemid 38294612)
33. Phan HH, Cho K, Nelson HA, Shin S, Jeong J, Greenhalgh DG. 2005. Downregulation of NF-kappaB activity associated with alteration in proliferative response in the spleen after burn injury. Shock 23:73-79. (Pubitemid 40083031)
34. Purcell EM, Dolan SM, Kriynovich S, Mannick JA, Lederer JA. 2006. Burn injury induces an early activation response by lymph node CD4+T cell. Shock 25:135-140.
35. Ralainirina N, Poli A, Michel TL. 2007. Control of NK cell functions by CD4+CD25+ regulatory T cells. J Leukoc Biol 81:144-153. (Pubitemid 46021263)
36. Sakaguchi S. 2004. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531-562. (Pubitemid 38680433)
37. Shultz DB, Fuller JD, Yang Y, Sizemore N, Rani MR, Stark GR. 2007. Activation of a subset of genes by IFN-gamma requires IKKbeta but not interferon-dependent activation of NF-kappaB. J Interferon Cytokine Res 27:875-884.
38. Stassen M, Schmitt E, Jonuleit H. 2004. Human CD4+CD25+ regulatory T cells and infectious tolerance. Transplantation 77:S23-S25. (Pubitemid 38114414)
39. Sunden-Cullberg J, Norrby-Teglund A, Treutiger CJ. 2006. The role of high mobility group box-1 protein in severe sepsis. Curr Opin Infect Dis 19:231-236. (Pubitemid 43740360)
40. Sutmuller RP, den Brok MH, Kramer M. 2006. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 116:485-494. (Pubitemid 43228366)
41. Thompson C, Powrie F. 2004. Regulatory T cells. Int Immunol 16:1241-1249.
42. Ulloa L, Messmer D. 2006. High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev 17:189-201. (Pubitemid 43949075)
43. Valencia X, Stephens G, Goldbach-Mansky R, Wilson M, Shevach EM, Lipsky PE. 2006. TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 108:253-261. (Pubitemid 43990636)
44. -lymphocytes. Crit Care Med 32:2329-2331. (Pubitemid 39491817)
45. Waterer GW. 2007. High-mobility group box 1 (HMGB1) as a potential therapeutic target in sepsis: more questions than answers. Crit Care Med 35:1205-1206. (Pubitemid 46598980)
46. Wisnoski N, Chung CS, Chen Y, Huang X, Ayala A. 2007. The contribution of CD4+ CD25+ T-regulatory-cells to immune suppression in sepsis. Shock 27:251-257.
47. Yamada S, Maruyama I. 2007. HMGB1, a novel inflammatory cytokine. Clin Chim Acta 375:36-42. (Pubitemid 44584241)
48. Zhang L, Zhao Y. 2007. The regulation of Foxp3 expression in regulatory CD4+CD25+T cells: multiple pathways on the road. J Cell Physiol 211:5900-5907.
49. Zhu XM, Yao YM, Liang HP, Xu S, Dong N, Yu Y, Sheng ZY. 2009. The effect of high mobility group box-1 protein on splenic dendritic cell maturation in rats. J Interferon Cytokine Res 29:677-686.
50. Zimmermann M. 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110. (Pubitemid 13058546)
51. Zwar TD, Read S, van Driel IR. 2006. CD4+CD25+ regulatory T cells inhibit the antigen-dependent expansion of self-reactive T cells in vivo. J Immunol 176:1609-1617. (Pubitemid 43134305)